Document Type

Response or Comment

Publication Date



This response supports the recommendations of the interagency working group for Bayh-Dole that the dataset collected and archived in iEdison “…be amended and expanded so that the agencies could get a clear picture of the commercialization plans for subject inventions, what the licensing landscape looked like, (and) what products were resulting, …”

Our comments are informed by several recent studies describing the effectiveness and reach of the Bayh-Dole Act in promoting and protecting the public interest in practical applications of government-funded biomedical research to pharmaceutical innovations.